Global /Sweden /Healthcare /Medical Devices /QLIFE

Qlife Holding AB (publ)

QLIFE

• STO: QLIFE • Delayed

1.89SEK -1.9%

0.1991 USD

As of 7 June 2026, Qlife Holding AB (publ) has a market cap of $5.92M USD, ranking #43768 globally and #715 in Sweden. It ranks #3884 in the Healthcare sector, and #820 in the Medical Devices industry.

Global Rank

43768

Country Rank

715

Sector Rank

3884

Industry Rank

820

Key Stats

Market Cap

$5.92MUSD

55.5M SEK

Enterprise Value

$6.61MUSD

62.63M SEK

Revenue (TTM)

$34.57KUSD

324.0K SEK

EBITDA (TTM)

-$1.91MUSD

-18.11M SEK

Net Income (TTM)

-$2.19MUSD

-20.56M SEK

PS Ratio

171.3

PB Ratio

-7.4

Company Profile

Country (HQ)

Sweden

Sector

Healthcare

Industry

Medical Devices

CEO

Thomas Warthoe open_in_new

Employees

Founded

2019

Website

qlifeholding.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.9%	3.7%	-3.4%	-8%	-12%	-32%	2.8%	-100%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
Nasdaq Stockholm (STO) MIC: XSTO PRIMARY	QLIFE Qlife Holding AB Ordinary Shares ISIN: SE0022574331 Shares Out.: Shares Outstanding: 28.874M¹ Shares Float: 28.851M² TV: TradingView: OMXSTO: QLIFE SA: Stock Analysis: STO: QLIFE YF: Yahoo Finance: QLIFE.ST GF: Google Finance: STO: QLIFE BA: Barron's: QLIFE MS: Morningstar: XSTO: QLIFE	1.89 SEK	TV: TradingView: OMXSTO: QLIFE SA: Stock Analysis: STO: QLIFE YF: Yahoo Finance: QLIFE.ST GF: Google Finance: STO: QLIFE BA: Barron's: QLIFE MS: Morningstar: XSTO: QLIFE

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Qlife Holding AB (publ)

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)

Name	Market Cap (USD) diff.	PE	Country
Getinge AB (publ) STO: GETI-B	$5.59B 52.4B SEK 94K%	22.2	Sweden
S SciBase Holding AB STO: SCIB	$4.85B 45.5B SEK 82K%	-	Sweden
Elekta AB (publ) STO: EKTA-B	$2.23B 20.86B SEK 37K%	-	Sweden
Vitrolife AB (publ) STO: VITR	$1.59B 14.87B SEK 27K%	-	Sweden
Bonesupport Holding AB (publ) STO: BONEX	$1.53B 14.32B SEK 26K%	78.5	Sweden
Xvivo Perfusion AB (publ) STO: XVIVO	$907.38M 8.5B SEK 15K%	115.1	Sweden

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 3M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 3M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 3M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 2M%	22.2	Ireland

chevron_leftBack